Aemetis, Inc. (AMTX) Stock Analysis

Company Overview

The market values Aemetis, Inc. (AMTX) at $132.07M. It is classified in the Specialty Chemicals industry, within the Basic Materials sector. The company reports 220 employees.

The most recent close on file for AMTX is $1.83, dated September 4, 2026. The close was unchanged from the previous session. Over the past 52 weeks the price has ranged from $1.30 to $3.80. The latest close sits 40.77% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $207.98M. That is −22.29% against the prior fiscal year, when revenue was $267.64M. The same year closed with a net loss of $77.00M. The reported profit margin is −26.14%. That is 26.2 percentage points below the Specialty Chemicals median of 0.08%. Trailing earnings per share are −0.86.

Across the 4 fiscal years on file, revenue moves from $256.51M in 2022 to $207.98M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The price-to-sales ratio is 0.57. On price-to-sales that is 65.82% below the Specialty Chemicals median of 1.68. The medians here are taken across 71 Specialty Chemicals companies that report the metric.

The reported beta is 1.47. Daily returns over the trailing 10 years annualize to a volatility of 118.96%. The trailing one-year price return is −24.69%. Across 10 years the annualized return works out at +2.50%.

Growth & Income

The record shows no dividend for AMTX.

Across the complete calendar years on file, 2021 returned +393.98% and 2022 returned −67.80%. Of the 9 complete calendar years on file, 5 finished higher. 2026 is still running; the price is +31.65% year to date.